The Trust has purchased the apartment on the 61st floor of Tower A, which is 17,384 sq ft big, according to documents ...

Zydus Family Trust purchased a luxury apartment in Mumbai's Oberoi Realty project for ₹200 crore. Covering 17,384 sq ft, the ...

The Zydus Family Trust, associated with Zydus Lifesciences Limited (formerly Cadila Healthcare Limited), a leading Indian ...

The Chan Zuckerberg Initiative (CZI) announced a new grand challenge to develop groundbreaking imaging technologies to transform how scientists observe, measure and understand living cells and ...

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) for IBS-D treatment. The company secured 180 days of shared ...

Zydus Lifesciences Ltd said it has successfully concluded a United States Food and Drug Administration (USFDA) surveillance inspection at its API Unit 1 in Ankleshwar in Gujarat. Inspection ...

Drug maker Zydus Lifesciences Ltd on Friday (March 14) announced the successful completion of a United States Food and Drug Administration (USFDA) inspection at its API Unit 1 in Ankleshwar, Gujarat.

Zydus Lifesciences share price today, March 13: The share price of Zydus Lifesciences has cracked 2.6% in the last five days. (Image: Freepik) Nuvama Institutional Equities slashed the target ...

Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus ...

Zydus Lifesciences Ltd on Tuesday, March 11, said that its board of directors has approved an acquisition of 85.6% equity stake in Amplitude Surgical SA, France. The deal is subject to signing a ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex ...

Zydus Lifesciences, one of India's leading drugmakers, is sprinting ahead of others to become a "beyond-the-pill" comprehensive healthcare solutions provider. Along with consumer health and ...